The cancer drug showed outstanding results compared to the current gold standard, tamoxifen. Indeed, Arimidex could be the ideal aromatase inhibitor - and judging by these results, AstraZeneca's marketing power will ensure that the drug becomes a major cancer product.
Edit my basket
© Datamonitor 2014. All rights reserved
Terms & Conditions